Embecta Investor Relations Material
Latest events
Investor Day 2025
Embecta
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Embecta Corp
Access all reports
Embecta Corp is a medical technology company focused on the development and manufacturing of diabetes care products. The company specializes in providing devices and solutions for insulin delivery, including insulin syringes and pen needles, aimed at improving the daily management of diabetes. Embecta serves healthcare providers and patients globally, with a mission to support individuals with diabetes in maintaining their health through reliable and accessible products. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Embecta Corp
43rd Annual J.P. Morgan Healthcare Conference 2025
Embecta Corp
Investor Day 2025
Embecta Corp
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
EMBC
Country
🇺🇸 United States